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Abstract
Treatment of infective endocarditis (IE) should be initiated promptly. This might hamper the chances to identify the causative
organism in blood cultures. Microbiological sampling of infected valve in patients undergoing surgery might identify the
causative organism. The impact of pre-operative antimicrobial treatment on the yield of valve samples is not known. This study
evaluated the impact of the duration of the pre-operative antibiotic treatment on valve culture and 16S rRNA PCR findings from
resected endocardial samples. Patients meeting the modified Duke criteria of definite or possible IE and undergoing valve surgery
due to IE during 2011–2016 were included from Southern Finland. Eighty-seven patients were included. In patients with shorter
than 2 weeks of pre-operative antimicrobial treatment, PCRwas positive in 91% (n = 42/46) and valve culture in 41% (n = 19/46)
of cases. However, in patients who had 2 weeks or longer therapy before operation, PCR was positive in 53% (n = 18/34) and all
valve cultures were negative. In 14% of patients, PCR had a diagnostic impact. In blood-culture negative cases (n = 13), PCR
could detect the causative organism in ten patients (77%). These included five cases of Bartonella quintana, one Tropheryma
whipplei, and one Coxiella burnetii. Long pre-operative antimicrobial treatment was shown to have a negative impact on
microbiological tests done on resected endocardial material. After 2 weeks of therapy, all valve cultures were negative, but
PCR was positive in half of the cases. PCR aided in diagnostic work-up, especially in blood culture negative cases.
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Introduction
Treatment of infective endocarditis (IE) is challenging. It de-
mands skills from different medical and surgical specialties
and necessitates promptly initiated and prolonged intravenous
antimicrobial therapy [1, 2]. Surgery is needed in almost half
of the cases [1]. An important prerequisite for optimal antibi-
otic therapy, and hence to a better prognosis, is identification
of the causative agent. In most cases, this is acquired from
blood cultures. In blood-culture negative cases, etiology may
be revealed by serological testing (e.g.,Bartonella quintana or
Coxiella burnetii antibody assay) or, in patients undergoing
valve surgery, by microbiological and molecular testing done
on resected heart valves [3, 4]. Of molecular methods, broad
range PCR has proven to be a useful diagnostic tool and more
sensitive than valve culture [5, 6]. However, the effect of an-
timicrobial treatment duration on diagnostic yield of valve
culture or PCR has not been characterized [6–11].
We collected data on all surgically treated patients with IE
during 6 years from a center taking care of a population of 1.9
million to study the impact of length of pre-operative antibi-
otic treatment on the diagnostic yield of valve cultures and
broad range bacterial 16S rRNA PCR. Another aim was to
evaluate the diagnostic impact of valve PCR and to gather
information on the non-cultivable agents behind IE in Finland.
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Materials and methods
The study design was a retrospective single-center study.
Patients (n = 115) who underwent cardiac surgery due to IE
in Helsinki University Hospital (HUH) during 2011–2016
were identified from the operating room’s database using
ICD-10 codes for infective endocarditis (I33, I38, and I39).
The inclusion criteria were the following: (1) a sample for
PCR analysis was obtained during surgery and (2) patients
were post-operatively classified as having possible or definite
IE according to modified Duke criteria [12]. The exclusion
criteria were the following: (1) a sample for PCR analysis
was not obtained during surgery (n = 22), (2) the data was
not available (n = 2), (3) IE was caused by yeast (n = 2), and
(4) IE diagnosis was rejected according to modified Duke
criteria (n = 2). In all, 87 patients were included in the final
analysis.
HUH is the sole provider of cardiac surgery in the Hospital
District of Helsinki and Uusimaa and two smaller adjacent
hospital districts in southern Finland. The population is 1.9
million and mainly urban, but rural areas are also included.
An infectious disease specialist (M.H.) reviewed all patient
data from the medical and laboratory records. Demographic
and clinical data were recorded.
Study definitions
Effective antibiotic treatment was defined as follows: an anti-
biotic treatment to which the causative agent was susceptible
to in vitro; an antibiotic treatment according to the European
Society of Cardiology guideline [2]; and delivered intrave-
nously. Duration of pre-operative treatment was calculated
from the first day of receipt of intravenous effective antibiotic
therapy to the operation day. Antibiotic therapy had to be
continuous. If patient had received a period of antibiotic ther-
apy previously, but it was discontinued more than 2 weeks
before admission, it was not included into duration of preop-
erative treatment.
Patients were divided into five groups depending on the
length of the pre-operative effective intravenous antibiotic
therapy as shown in Table 1. The last group (n = 7) consisted
of patients who received less than 1 week of intravenous ther-
apy before surgery but had a longer continuous oral and
intravenous treatment before it. In most cases, their longer
course had targeted foci other than IE. Thus, this group is left
out of the time analysis, because true length of effective ther-
apy could not be determined.
A result from PCR analysis was considered to have a diag-
nostic impact in the following situations: (1) it revealed etiol-
ogy of IE when blood cultures were negative, (2) it confirmed
positive serological tests, or (3) it resolved etiology of IEwhen
there was a discrepancy between blood and valve cultures.
Microbiological procedures
In HUH, microbiological and histological sampling is routine-
ly done in operative treatment of patients with IE. Since 2010,
surgeons have been advised to routinely include also a sample
for PCR analysis along with other microbial samples (mainly
bacterial cultures). Hence, this study evaluates the impact of
PCR analysis implemented in routine clinical setting. From 87
patients included, 89 samples for PCR were obtained. In two
cases, two samples were obtained and in the rest of the cases,
one. In 80 cases, a sample for PCR was taken from the valve
tissue or the vegetation and in 7 from pus, e.g., a paravalvular
abscess. A total of 101 valve culture samples were obtained.
One sample per patient was obtained in 73 cases and two
samples in 14 cases. All valve culture and PCR results are
presented per patient. These samples were sent immediately
to laboratory (HUSLAB, Helsinki) for analysis. If necessary,
samples were stored maximally for 2 days in +4 °C before
analysis.
Blood cultures in cases with suspected IE were taken as
routine protocol as ordered by the treating physicians. Blood
samples were incubated in blood culture bottles in
BacT/Alert® (BioMérieux, France) instrument a total of 5–
6 days or until reported as positive, where after the microbe
was identified by routine diagnostic methods.
The clinical samples were cultured by routine diagnostics
at HUSLAB (Helsinki University Hospital Laboratory,
Helsinki, Finland) using standard methods. Briefly, samples
were cultivated on chocolate agar and fastidious anaerobe agar
and incubated at 37 °C until growth was observed or for max-
imum 7 days in 5% CO2 or under anaerobic conditions, re-
spectively. In addition, samples were also inoculated into the
thioglycollate broth and cultivated at 37 °C.
Table 1 Impact of pre-operative
antibiotic treatment on PCR re-
sults and valve cultures
Intravenous antibiotic treatment started







On operation day (or after) 11 10 (90.9) 4 (36.4)
Within 2–13 days before operation 35 32 (91.4) 15 (42.9)
Within 14–28 days before operation 17 10 (58.8) 0
More than 28 days before operation 17 8 (47.1) 0
Within 7 days before operation, but previous longer course 7 4 (57.1) 0
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For 16S rRNA analysis, the clinical samples were homog-
enized using a Precellys bead-beater (Bertin Instruments) and
DNAwas extracted with SelectNAplus (Molzym) instrument
or previously with Easymag (BioMérieux) (see Supplement
Table 1). Each method has been validated and no different
effect on positivity rate has been observed. The ribosomal
16S DNA was amplified using primers Forward CLSI and
Reverse Bosshard [13]. Used polymerases, PCR instruments,
and thermal cycling conditions are specified in Supplement
Table 1. PCR-amplified fragments were separated using gel
electrophoresis and visualized under ultraviolet light.
Amplified fragments were purified and sequenced with a
BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo
Fisher Scientific) using forward Bosshard primer [13] and an
ABI Prism 3100 genetic analyzer (Thermo Fisher Scientific).
Then analysis was performed by Basic Local Alignment
Search Tool (BLAST; National Center for Biotechnology
Information, Bethesda, MD, USA. https://blast.ncbi.nlm.nih.
gov/Blast.cgi). An inhibition control (amplification of lambda
DNA orOryza sativa gene) was tested with each sample and a
nontemplate control was tested with each run.
Statistical analysis
Categorical data was analyzed by chi-square test or Fisher’s
exact test, as appropriate. Continuous variables were analyzed
withMann-WhitneyU test. Statistical analysis was done using
SPSS Software, version 22.0 (SPSS, Inc. Chicago, Illinois).
Results
In total, 87 patients were included and their mean age was
52.7 years and 71 (81.6%) of them were male. Patient demo-
graphics and medical history are shown in Table 2. Data on
valve surgery and clinical features are shown in Table 3.
Definite IE was observed in 85 patients and 2 patients had
possible IE according to modified Duke criteria [12].
Blood and valve cultures
Blood cultures were positive in 74 (85%) cases (Table 4).
Most common findings were Staphylococcus aureus (n =
24) , Streptococcus vir idans group (n = 22) , and
Enterococcus faecalis (n = 9).
Valve cultures were positive in 19 (22%) cases. In two
cases, the valve culture result differed from the blood culture
result. In one case, Streptococcus mitis did not grow on the
blood cultures, but it was cultured from the valve and found in
PCR analysis. In the other case, Staphylococcus epidermidis
grew on the valve culture but Streptococcus salivarius was
found in the blood cultures and valve PCR analysis. In this
case, Staphylococcus epidermidis was regarded as a
contaminant. Additionally, in one patientCutibacterium acnes
grew on culture. However, this sample was taken from a me-
diastinal site and blood cultures were positive for
Enterococcus faecalis. Thus, this finding was ruled as a con-
taminant after infectious disease specialist’s consultation. In
cases were two valve samples were taken, only in one case the
results differed (one negative and the other positive).
16S rRNA PCR and sequencing
In 64 cases (74%), PCR analysis was positive (Table 4). Of
these cases, 54 were also blood-culture positive with consis-
tent results and 10 were blood culture negative. In only one
case valve culture was positive (Staphylococcus aureus), but
PCR remained negative. In blood-culture negative cases (n =
13), PCR analysis identified the causative agent in 10 (77%).
In one case, a mixed sequence was suspected with
Streptococcus mitis and possibly in addition other
Streptococcus viridans group species. However, in this case,
Streptococcus mitis grew on blood cultures. In two cases, two
samples for PCR were taken. In both cases, the two samples
were both positive with similar result (i.e., same bacteria).
We identified 12 cases where valve PCR was considered to
have a diagnostic impact (Table 5).
Impact of duration of antibiotic therapy on valve
cultures and PCR findings
Patients were categorized according to the length of the pre-
operative effective intravenous antibiotic therapy as shown in
Table 1. After excluding the seven patients in whom the du-
ration of effective antimicrobial therapy was uncertain (as de-
scribed in detail in Study definitions paragraph), we chose to
compare the groups with antibiotic duration less than 2 weeks
with the groups with antibiotic duration more than 2 weeks.
The proportion of PCR-positivity in those patients who re-
ceived effective antimicrobial therapy less than 2 weeks be-
fore surgery was 91% (n = 42/46) and in patients who received
it more than 2 weeks 53% (n = 18/34); p = 0.00009; chi-
square.
To control for possible confounding, independent variables
associated with PCR-positivity in univariate analysis (p value
< 0.20 or clinical significance, Supplement Table 2) were in-
cluded in a logistic regression analysis. Only duration of pre-
operative antibiotic treatment less than 2 weeks remained as a
significant denominator for PCR-positivity (OR 7.2, 95% CI
2.0–26.0; p = 0.003).
The median duration of pre-operative antibiotic therapy in
PCR-positive patients (n = 60) was 8.5 days and in PCR-
negative (n = 19) 24.0 days, p = 0.001 (Fig. 1). One patient
who received more than 4 weeks of pre-operative antibiotic
treatment was additionally excluded from this median
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duration time analysis, because the exact duration of the anti-
biotic therapy could not be determined.
All valve culture positive patients (n = 19) received antibi-
otic therapy less than 2 weeks before surgery.
Discussion
In this study, we observed that longer than 2 weeks of antimi-
crobial treatment totally abolished valve cultures and signifi-
cantly reduced also the yield of valve bacterial PCR.
However, even after 2 weeks of treatment PCR detected caus-
ative agent in more than half of the cases. 16S rRNA PCR
contributed to the etiological diagnosis in 14% of cases. It
showed benefit especially in blood culture negative cases in
which 16S rRNA PCR could detect the causative agent in
77% of cases. In addition, we observed five cases of
Bartonella quintana and one of Coxiella burnetii and
Tropheryma whipplei each, which all have previously thought
to be very rare in Northern Europe.
Effect of pre-operative antibiotic treatment on valve cul-
tures is controversial, as two studies found no effect [6, 11],
but two reported a negative effect [7, 9]. In our material, we
had no positive valve cultures after 2 weeks of antimicrobial
treatment. In accordance, only one valve culture was positive
after 2 weeks of antibiotic treatment among 131 cases of strep-
tococcal endocarditis [10].
In a study by Peeters et al. most (19/24) patients had a
causative agent detected with 16S rRNA PCR even after
21 days of antibiotic therapy [6] and another study could not
confirm any correlation between the length of pre-operative
antibiotic treatment and positive PCR results [9]. Rovery et al.
demonstrated that bacterial DNA may persist in heart valves
for a long time after successful treatment and does not neces-
sarily represent viable organisms [8]. However, in patients
who underwent valve surgery while still on antibiotic treat-
ment, bacterial DNA was detected significantly more often
compared to patients who had completed the treatment.
They concluded that bacterial DNA was cleared over time,
but slowly. In the present study, 74% of patients had positive
PCR results. In previous studies, the sensitivity of PCR ranged
from 40 to 100% [5, 6]. However, after 2 weeks of effective
intravenous antibiotic therapy, PCR positivity dropped mark-
edly, but half were still positive. Our results suggest that in a
real-life setup where PCR is included into routine operative
procedures, pre-operative antimicrobial treatment seems also
Table 2 Demographics and
medical history of the study
cohort
Demographics (n = 87) Age, years (mean) 52.7
Male 71 (81.6%)
Medical history Pre-disposing and pre-existing structural heart disease 24 (27.6)
Previous IE 7 (8.0)
Chronic kidney disease 4a (4.6)




IVDU intravenous drug users
a 3 hemodialysis, 1 peritoneal dialysis
Table 3 Valves operated due to
IE and clinical data of study
cohort
Number of valves operated (n = 105)




Number of patients (% of all)
Type of valve Native 76 (87.4)
Cardiac device involved 2 (2.3)
Additional clinical data Septic emboli (or deep focus) 48 (55.2)
Relapse of IE within 12 months 4 (4.6)
30-day all-cause mortality 7 (8)
365-day all-cause mortality 15 (17.2)
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to reduce the yield of PCR. Furthermore, patients with a pos-
itive PCR test result had also shorter median duration of pre-
operative antibiotic therapy than PCR negative cases.
Interestingly, in one case, PCR test could still detect bacte-
rial DNA in the resected heart valve after 6 months of contin-
uous antibiotic therapy. This patient had blood culture positive
IE caused by Granulicatella adiacens and had a long
intravenous antibiotic treatment initially. At the time of sur-
gery, the patient was still on oral antibiotic therapy due to
concomitant spondylodiscitis. After operation, the antibiotic
therapy was discontinued and in follow-up, no relapse
occurred.
One previous study from Finland evaluated 56 cases of IE
requiring surgery and found that in 4 cases (7%) the causative
Table 4 Results of blood
cultures, valve cultures, and PCR
samples. Number of patients with
each microbe is shown
Microbe Blood culture Valve culture PCR
Blood culture positive cases (n = 74)
Staphylococcus aureus 25a 6 20
Streptococcus viridans groupb 20 2 15
Enterococcus faecalis 9 2 4
Coagulase negative staphylococcus 8c 4d 4
Streptococcus agalactiae 4 1 4
Other beta-hemolytic streptococci 4e 0 3
Streptococcus pneumoniae 1 0 0
Streptococcus bovis 1 1 1
Streptococcus anginosus 1 1 1
Granulicatella adiacens 1 0 1
Aerococcus urinae 1 1 1
Blood culture negative cases, but PCR positive (n = 10)
Bartonella quintana 0 0 5
Coxiella burnetii 0 0 1
Tropheryma whipplei 0 0 1
Streptococcus pneumoniae 0 0 1
Streptococcus viridans group 0 1 2
IE cases without determined etiology (n = 3)
a In 2 cases, polymicrobial bacteremia (1 with Bacillus cereus and 1 with Streptococcus agalactiae and in this case
Staphylococcus aureus was not considered as causative agent of IE)
b Streptococcus anginosus and Streptococcus bovis are shown separately
c 4 Staphylococcus epidermidis, 3 Staphylococcus lugdunensis
d 3 concordant with BC (same cases); 1 different case (ruled as contamination in that case)
e 3 G group and 1 C group
Table 5 Cases in which PCR finding had a diagnostic impact (n = 12, 13.8%)
PCR finding Number
of cases
Type of impact Comments
Bartonella quintana 5 Serological findings confirmed Cultures negative; serology tested and positive in 3 cases
Coxiella burnetii 1 Serological findings confirmed Serology positive; cultures negative
Tropheryma whipplei 1 Etiology of IE provided No serological tests available and bacteria cannot be cultured
Streptococcus gordonii 1 Etiology of IE provided Both valve and blood cultures negative; antibiotic treatment started before cultures
Str. pneumoniae 1 Etiology of IE provided Both valve and blood cultures negative, antibiotic started before cultures
Str. agalactiae 1 Etiology of IE confirmed;
discrepancy between
valve and blood cultures
Valve culture negative; Str. agalactiae and Staphylococcus aureus both in blood
cultures
Str. salivarius 1 As above Str. salivarius in blood cultures; Staphylococcus epidermidis in valve culturea
Str. mitis 1 As above Blood cultures negative; Streptococcus mitis in valve culture
IE, infective endocarditis; Str., streptococcus
a This culture result was ruled as a contaminant
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agent was detected only by 16S rDNA PCR [7]. This study
was done in a different region in Finland than our study and
included the first published case of Bartonella quintana IE in
Finland. A Swedish study including 57 patients found 16S
rDNA PCR particularly useful in blood culture negative cases
but included no cases due to Bartonella spp. [14]. In two
studies from Denmark, including patients with IE undergoing
surgery and molecular diagnostic methods, no cases of
Bartonella spp. were reported either [9, 15]. Here, we report
five cases of IE caused by Bartonella quintana, one caused by
Coxiella burnetii (etiological agent in Q-fever) and one caused
by Tropheryma whipplei which all have previously been re-
ported mainly from Southern Europe. Furthermore, two more
cases of IE caused by Tropheryma whipplei have been ob-
served in our hospital outside the study period.
The present study adds to the weight of evidence of diag-
nostic value of PCR in surgically treated IE patients. In a
Canadian study of 68 patients, molecular methods contributed
to the microbial diagnosis of 31% of patients with IE requiring
valve surgery and contributed to the clinical decisions in 13%
[5]. Similarly, in a French study, valve PCR contributed to the
microbiological etiology of IE in 20% of patients [4].
In this study, all bacteria found by PCR in the culture neg-
ative cases were organisms recognized to cause IE and not
usually regarded as contaminants. In PCR negative cases,
we cannot rule out the possibility of false-negative cases due
to sampling errors. In some studies, there have been a high
number of false-positive valve cultures raising a concern of
their utility [8, 16]. However, in our study, only two valve
cultures were ruled as contaminants.
The present study is from a single center which, how-
ever, is the sole provider of cardiac surgery in its
recruitment area. Thus, we believe that virtually all patients
from this area undergoing valve surgery for IE are included
in this study as long as we have been able to identify the
cases from the hospital records. Considering that infective
endocarditis is a relatively rare condition that requires sur-
gery in almost 50% of the episodes, the 87 patients of our
study make it one of the largest of its kind. One of the main
limitations of our study was its retrospective nature making
it impossible to rule out a selection bias, especially when
22 patients were excluded because sample for PCR was not
taken in spite of the hospital protocol. However, 12 of
these occurred in year 2011 (the first year) and the remain-
ing one to three cases annually. So, the most likely expla-
nation is that surgeons had not yet adopted a new protocol
rather than other systematic bias. Operating surgeons were
instructed to take a sample for PCR from the vegetation or
the visually infected valve tissue. Depending on the oper-
ative situation, the extent and intensity of the infection, the
amount and the quality of the sample may have varied.
More standardized sampling recommendations for PCR
analysis might be needed.
In conclusion, 16S rRNA PCR was a valuable tool in
etiological diagnosis of IE in patients undergoing valve
surgery and especially in those with longer pre-operative
antibiotic treatment and in blood-culture negative IE.
Although the length of pre-operative antibiotic therapy
had a negative effect on the yield of both valve cultures
and PCR, after 2 weeks of antibiotic therapy, PCR was
positive in nearly half of the patients. Bartonella quintana,
Coxiella burnetii, and Tropheryma whipplei may present as
causative agents also in the Northern Europe and seem to
be found by valve PCR sampling.
Fig. 1 Duration of pre-operative
antimicrobial therapy and PCR
results. Bars show the median
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